
DERMTECH ALERT: Bragar Eagel & Squire, P.C. Is Investigating Dermtech, Inc. On Behalf Of Long-Term Stockholders And Encourages Investors To Contact The Firm
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants allegedly failed to disclose to investors: (1) that the Company experienced challenges with collections from commercial payors; (2) that, as a result, there was a lower average selling price for DermTech's DMT; (3) that, as a result of the foregoing, the Company's revenue growth would be adversely impacted; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you are a long-term stockholder of DermTech, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at ... , by telephone at (212) 355-4648, or by filling out this contact form . There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn , X , and Facebook , and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X .
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
...


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Tommaso Caratelli Introduces Zerix, Focusing On Innovative Risk Strategies
- Stably Introduces Stablecoin Development & Advisory Services For Institutions & Enterprises
- B2PRIME Appoints Former Onezero Sales Head Stuart Brock As Institutional Business Development Manager
- Roam Launches On Binance Alpha And Solana's Meteora DEX, Expands Cross-Chain Access Via BSC Integration
- FBS Releases Market Outlook On Bitcoin Following US-China Trade Truce
- Reddio's Exclusive Token Generation Event (TGE) And Alpha Trading On Binance Wallet - May 29, 2025
Comments
No comment